Biomerica, Inc. (NASDAQ:BMRA) Short Interest Down 7.6% in January

Biomerica, Inc. (NASDAQ:BMRA) was the target of a significant drop in short interest in the month of January. As of January 31st, there was short interest totalling 254,500 shares, a drop of 7.6% from the January 15th total of 275,500 shares. Based on an average trading volume of 7,530,000 shares, the days-to-cover ratio is currently 0.0 days.

Biomerica Price Performance

Shares of NASDAQ:BMRA opened at $1.03 on Wednesday. The stock has a market cap of $18.89 million, a price-to-earnings ratio of -3.03 and a beta of -0.98. Biomerica has a 12 month low of $0.24 and a 12 month high of $1.35. The stock’s 50 day moving average price is $0.46 and its 200 day moving average price is $0.39.

Biomerica (NASDAQ:BMRA) last issued its quarterly earnings results on Tuesday, January 14th. The company reported ($0.06) earnings per share (EPS) for the quarter. Biomerica had a negative net margin of 100.52% and a negative return on equity of 90.19%.

Institutional Investors Weigh In On Biomerica

An institutional investor recently raised its position in Biomerica stock. Granahan Investment Management LLC lifted its holdings in Biomerica, Inc. (NASDAQ:BMRA) by 24.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 658,767 shares of the company’s stock after purchasing an additional 131,306 shares during the period. Granahan Investment Management LLC owned about 3.59% of Biomerica worth $198,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 22.28% of the company’s stock.

Biomerica Company Profile

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.